Today: 7 February 2026
Subscribe
Browse Category

Mergers & Acquisitions News 1 October 2025 - 10 October 2025

Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play

Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play

In-Depth Analysis BMS’s acquisition of Orbital Therapeutics marks a deliberate push into autoimmune disease treatment via advanced cell therapy. Orbital, founded in 2022 by leaders in RNA and immunology, has built a proprietary RNA platform combining circular and linear RNA engineering with sophisticated lipid nanoparticle (LNP) delivery Bms Fiercebiotech. Its lead program, OTX-201, is designed as an in vivo CAR‑T: instead of harvesting and engineering cells outside the body, Orbital will inject circular RNA encoding a CD19-directed CAR into the patient, so the patient’s own T cells become the “manufacturers” of CAR‑T cells in situ Bms Orbitaltx. This approach could
10 October 2025
·····
MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

Company Background & Business Model MEDIROM Healthcare Technologies (NASDAQ: MRM) is a Tokyo‑based provider of holistic health and wellness services. Founded in 2000, it operates 300+ Re.Ra.Ku branded relaxation salons across Japan medirom.co.jp, offering massage, aromatherapy and lifestyle therapy. These salons generate the bulk of revenues (47.3M of $52.7M in 2024) ir.medirom.co.jp. In parallel, since 2015 MEDIROM has built a Digital Preventative Healthcare arm. Key elements are: the Lav® on-demand health‐guidance app, and the MOTHER Bracelet®, a battery‑free wearable activity tracker. In 2023 it launched REMONY, a remote health monitoring service bundling the MOTHER Bracelet with corporate wellness programs medirom.co.jp.
9 October 2025
····
Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Sources: Akero Therapeutics investor materials; Novo Nordisk press statements; Reuters, TS2.tech and FierceBiotechnews reportsts2.techts2.techfiercebiotech.com; MarketBeat and DirectorsTalk analyst surveysmarketbeat.comdirectorstalkinterviews.com; Economic Times deal summaryeconomictimes.indiatimes.comeconomictimes.indiatimes.com; Business Wire legal alertbusinesswire.combusinesswire.com; and TradingView market datamarketbeat.comtradingview.com.
9 October 2025
····
Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Confluent (CFLT) Stock Surges on Takeover Rumors – What’s Next for the Data Streaming Pioneer?

Latest News and Developments Confluent’s headquarters in Silicon Valley. The company’s rumored sale exploration has made headlines, spurring a surge in its stock price as investors speculate on a potential acquisition. The biggest recent news for Confluent came on October 8, 2025, when a Reuters exclusive reported that the company is exploring a sale after receiving takeover interestreuters.com. According to the report, multiple private equity firms and tech companies approached Confluent, prompting it to work with an investment bank on a possible dealreuters.com. This development reflects how valuable real-time data streaming has become in the age of AI – Confluent’s technology is seen as a
8 October 2025
····
Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Stock Price & Short‑Term Performance Confluent trades on the NASDAQ under ticker CFLT. According to the company’s historical price lookup, the stock closed at $21.26 on 6 Oct 2025 and dropped to $20.73 on 7 Octinvestors.confluent.io. Technical analysis from StockInvest.us notes the stock fell 2.49 % on 7 Oct, trading between $20.12 and $21.33, and it has declined in six of the last ten sessionsstockinvest.us. Volume was ~7 M shares, lower than earlier sessions, suggesting reduced riskstockinvest.us. The near‑term outlook is cautious: the share price is in a falling short‑term trend with predicted downside of almost 19 % if the trend persists. However, both short‑ and long‑term
8 October 2025
····
Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Fifth Third’s $10.9 B Comerica Takeover Shakes Up Banking – Will Comerica Park Get a New Name?

A $10.9 B Deal to Create a Top-10 Bank Fifth Third Bancorp, based in Cincinnati, agreed to acquire Comerica Inc. of Dallas in an all-stock transaction valued at $10.9 billionreuters.com. The merger will form the nation’s ninth-largest bank by assets, a financial giant with approximately $288 billion in total assets and a deep footprint across multiple regionsreuters.comts2.tech. Under the deal terms announced October 6, each Comerica share will be exchanged for 1.8663 shares of Fifth Third stockir.53.com. At Fifth Third’s pre-announcement share price, that equates to $82.88 per Comerica share, representing about a 20% premium over Comerica’s recent average trading priceir.53.comts2.tech. When the
6 October 2025
···
Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Current Stock Performance & Market Reaction The announcement of Fifth Third Bancorp’s planned acquisition of Comerica sent CMA stock soaring. On 6 October 2025, Comerica’s investor‑relations website showed the stock opening near $81.00 and trading around $79.62–$80.56, up 9–14 % from the previous closeinvestor.comerica.com. MarketWatch reported that CMA shares rallied 15.1 % to $81.20, a three‑year high, while Fifth Third’s shares dipped 0.3 %morningstar.com. The initial spike reflected the generous 20 % premium offered by Fifth Third and expectations that the combined bank would command more market share. Investors also reacted to a brighter regulatory outlook. Reuters noted that U.S. regulators have streamlined bank‑merger reviews, reversing
6 October 2025
···
White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains Stock Rockets +10% on $1.75B Bamboo Deal – What Investors Need to Know

Figure: White Mountains’ share price spiked on Oct. 3, 2025 after announcing the $1.75B Bamboo sale reuters.com investing.com. Stock Surge on Oct. 3, 2025 White Mountains saw one of its biggest single-day moves in years on Oct. 3, 2025. After closing the prior day near $1,665, WTM stock jumped nearly 11% intraday reuters.com, settling around $1,841 by market close (a gain of +10.62% from the previous close). This surge was driven by the surprise announcement that morning: WTM signed an agreement to sell most of its Bamboo homeowners insurance business to private equity firm CVC reuters.com investing.com. Investors reacted strongly because Bamboo had been
3 October 2025
···
White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

Stock Performance & Market Data Price: As of Oct 3, 2025 (morning), WTM is trading around $1,820 per share markets.financialcontent.com. It opened near $1,785 and hit intraday highs ~$1,863 markets.financialcontent.com. This is significantly above the prior close of $1,664.56 on Oct 2 markets.financialcontent.com. The stock’s 52-week range is roughly $1,648–$2,023 investing.com. Daily Move: The Oct 3 rally (up ≈9.3%) was driven by the Bamboo sale announcement. YTD: For 2025, WTM is down about 5.7% markets.financialcontent.com. Over the past week, the stock had been near its 52-week low (~$1,650) before rebounding on Oct 3. Volume: The price jump was on moderate
3 October 2025
·····
USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

USA Rare Earth (USAR) Stock Explodes on Trump Admin Talks, $100M UK Acquisition & Rare Earth Rally

Stock Performance & Technicals USA Rare Earth has been on a tear through late 2025. After a relatively flat first half, shares began climbing in August, roughly doubling from ~$12 in early Sept to over $25 by early Oct. The Oct 2 close at $22.71 represented a new high, and pre-market Oct 3 trading at ~$26.20 stockanalysis.com pushes the stock sharply above its 50-day (≈$15.5) and 200-day (≈$12.3) moving averages stockanalysis.com. The surge reflects extremely strong bullish momentum: the 14-day RSI is near 80 (technically “overbought”), and average daily volume has spiked well above historical norms (Oct 2 saw ~22.8M
3 October 2025
····
USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

Stock Surge & Financials USA Rare Earth’s stock has been on a tear. After trading around $5–6 at the start of 2025, it climbed steadily as the company hit milestones, and on Oct 3, 2025 it burst higher. In pre-market on Oct 3, shares jumped about 10% after CEO Barbara Humpton said USAR was in “close discussions” with the White House on critical minerals supply reuters.com. This echoes reports that the Trump administration (via emergency powers) is actively boosting domestic rare-earth projects, alongside stakes in lithium companies and deals with MP Materials reuters.com investing.com. By midday Oct 3, Reuters noted USAR stock
3 October 2025
·····
AES Corp Stock Skyrockets as BlackRock Nears $38B Takeover – What Investors Need to Know /updated: 3:00 PM EDT/

AES Corp Stock Skyrockets as BlackRock Nears $38B Takeover – What Investors Need to Know /updated: 3:00 PM EDT/

Stock Price & Recent Trading AES shares have rallied sharply in late September. As of Oct 1 the stock was around $15.3 – up over 15% on the day reuters.com. This was the largest single-day jump in nearly a year, triggered by takeover rumors. Trading volume spiked; Reuters notes AES was “boosting the S&P 500 utilities sector” as investors flocked in reuters.com. Before this move, AES had been in a year-long slump (down ~30% from last year’s high), but a minor rebound in recent weeks was dramatically accelerated by the BlackRock/GIP news. Over the last few days (Sept 28–Oct 1) the stock gyrated on deal speculation:
1 October 2025
······
1 … 30 31 32 33 34

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop